> Back to Indiviual Listing
> Back to Drug Listing
Cerecin, Inc.
44 Cook Street
Suite 100-71
Denver, CO 80206
Website:
www.cerecin.com
Email:
info@cerecin.com
Phone:
(303) 999-3700
Number of Employees: 51-200
A CNS therapeutics company addressing unmet medical needs in brain health, including Alzheimer’s disease. Accera is focused on the clinical development of drugs with innovative mechanisms of actions. The company’s management team includes globally recognized specialists in central nervous system diseases and drug development, who together leverage the latest scientific knowledge and understanding of neurological disorders.
General Management
R&D/Regulatory
Drugs
Name
Title
Phone
Email
Charles Stacey, MD
President/CEO
cstacey@accerapharma.com
Jerris Knaisch
VP, Finance & NA Operations
jerris.knaisch@accerapharma.com
Judy Walker, MD
Chief Medical Officer
Samuel Henderson, PhD
Chief Scientific Officer
x702
Bruce Morimoto
VP, Drug Development
General Management
Charles Stacey, MD
President/CEO
cstacey@accerapharma.com
Jerris Knaisch
VP, Finance & NA Operations
jerris.knaisch@accerapharma.com
R&D/Regulatory
Judy Walker, MD
Chief Medical Officer
Samuel Henderson, PhD
Chief Scientific Officer
702
Bruce Morimoto
VP, Drug Development
AXONA
; Vitamins/minerals/supplements